Barr launches generic Razadyne in US
This article was originally published in Scrip
Executive Summary
Barr Pharmaceuticalshas launched the first US generic version ofJohnson & Johnson's Razadyne (galantamine hydrobromide) tablets for Alzheimer's dementia following a federal court ruling invalidating the innovator's patent.